How embolism proof is the Embrella Embolic Deflector system?

@article{Mieghem2014HowEP,
  title={How embolism proof is the Embrella Embolic Deflector system?},
  author={Nicolas M D A van Mieghem and Aad van der Lugt},
  journal={JACC. Cardiovascular interventions},
  year={2014},
  volume={7 10},
  pages={1156-8}
}
SEE PAGE 1146 U pdated guidelines on valvular heart disease from both sides of the Atlantic have endorsed transcatheter aortic valve replacement (TAVR) for treatment of symptomatic patients with severe aortic valve stenosis (AS) at (very) high risk for post-operative mortality (1,2). Following the publication of the PARTNER (Placement of AoRtic TraNscathetER Valves) Cohorts A and B randomized trial results, the stigma of excessive cerebrovascular events was associated with TAVR (3,4). Of note… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 16 references

First - inman experience with a new embolic de fl ection device in transcatheter aortic valve interventions

  • K Onsea, P Agostoni, M Samim
  • EuroIntervention
  • 2012

Similar Papers

Loading similar papers…